A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome
Sabrina Bagaglio(Vita-Salute San Raffaele University), Giulia Morsica(Vita-Salute San Raffaele University), Riccardo Vercesi(IRCCS Ospedale San Raffaele), Luca Peano(Azienda USL della Valle d’Aosta), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Hamid Hasson(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University)
Cited by 4
Related Papers
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168
Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy
|Annals of Internal Medicine|2002|136
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133